HealthTronics OssaTron Lithotripter PMA Submission Planned By Year-End
This article was originally published in The Gray Sheet
Executive Summary
A premarket approval application for HealthTronics' OssaTron lithotripter for treatment of chronic heel pain due to planar fasciitis should be submitted to FDA by December.